MoneyWorks4Me

The revenue zoomed 15.93% to Rs. 9702.93 millions for the quarter ended June 2024 as compared to Rs. 8369.58 millions during the corresponding quarter last year.A humble growth in net profit of 11.66% reported in the quarter ended June 2024 to Rs. 404.46  millions from Rs. 362.22 millions.Operating Profit saw a handsome growth to 1476.94 millions from 1328.90 millions in the quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202406 202306 % Var
Sales 9702.93 8369.58 15.93 9702.93 8369.58 15.93 9702.93 8369.58 15.93
Other Income 325.06 214.22 51.74 325.06 214.22 51.74 325.06 214.22 51.74
PBIDT 1476.94 1328.90 11.14 1476.94 1328.90 11.14 1476.94 1328.90 11.14
Interest 375.67 387.22 -2.98 375.67 387.22 -2.98 375.67 387.22 -2.98
PBDT 1101.27 941.68 16.95 1101.27 941.68 16.95 1101.27 941.68 16.95
Depreciation 550.79 462.95 18.97 550.79 462.95 18.97 550.79 462.95 18.97
PBT 550.48 478.73 14.99 550.48 478.73 14.99 550.48 478.73 14.99
TAX 146.02 116.51 25.33 146.02 116.51 25.33 146.02 116.51 25.33
Deferred Tax 16.89 -1.56 -1182.69 16.89 -1.56 -1182.69 16.89 -1.56 -1182.69
PAT 404.46 362.22 11.66 404.46 362.22 11.66 404.46 362.22 11.66
Equity 1811.52 1808.52 0.17 1811.52 1808.52 0.17 1811.52 1808.52 0.17
PBIDTM(%) 15.22 15.88 -4.13 15.22 15.88 -4.13 15.22 15.88 -4.13
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..